{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:08:09Z","timestamp":1774490889876,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Enterovirus 71 (EV71) is a major pathogen of hand, foot, and mouth disease\u00a0(HFMD). To date, no antiviral drug has been approved to treat EV71 infection. Due to the essential role that EV71 3\u2009C protease (3C<jats:sup>pro<\/jats:sup>) plays in the viral life cycle, it is generally considered as a highly appealing target for antiviral drug development. In this study, we present a transgene-encoded biosensor that can accurately, sensitively and quantitatively report the proteolytic activity of EV71 3C<jats:sup>pro<\/jats:sup>. This biosensor is based on the catalyzed activity of a pro\u2013interleukin (IL)-1\u03b2-enterovirus 3C<jats:sup>pro<\/jats:sup>cleavage site-<jats:italic>Gaussia<\/jats:italic>Luciferase (GLuc) fusion protein that we named i-3CS-GLuc. GLuc enzyme is inactive in the fusion protein because of aggregation caused by pro\u2013IL-1\u03b2. However, the 3C<jats:sup>pro<\/jats:sup>of EV71 and other enteroviruses, such as coxsackievirus A9 (CVA9), coxsackievirus B3 (CVB3), and poliovirus can recognize and process the canonical enterovirus 3C<jats:sup>pro<\/jats:sup>cleavage site between pro\u2013IL-1\u03b2 and GLuc, thereby releasing and activating GLuc and resulting in increased luciferase activity. The high sensitivity, ease of use, and applicability as a transgene in cell-based assays of i-3CS-GLuc biosensor make it a powerful tool for studying viral protease proteolytic events in living cells and for achieving high-throughput screening of antiviral agents.<\/jats:p>","DOI":"10.1038\/s41598-017-10840-x","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T14:37:39Z","timestamp":1504017459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of a luciferase-based biosensor to assess enterovirus 71 3C protease activity in living cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianliang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caishang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"10840_CR1","first-page":"200","volume":"22","author":"CY Chen","year":"2001","unstructured":"Chen, C. Y. et al. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. American Journal of Neuroradiology 22, 200\u2013205 (2001).","journal-title":"American Journal of Neuroradiology"},{"key":"10840_CR2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/INF.0b013e3181a41d63","volume":"28","author":"TC Lee","year":"2009","unstructured":"Lee, T. C. et al. Diseases Caused by Enterovirus 71 Infection. Pediatric Infectious Disease Journal 28, 904\u2013910 (2009).","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10840_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","volume":"129","author":"NJ Schmidt","year":"1974","unstructured":"Schmidt, N. J., Lennette, E. H. & Ho, H. H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129, 304\u20139 (1974).","journal-title":"J Infect Dis"},{"key":"10840_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1086\/318454","volume":"32","author":"P McMinn","year":"2001","unstructured":"McMinn, P., Stratov, I., Nagarajan, L. & Davis, S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clinical Infectious Diseases 32, 236\u2013242 (2001).","journal-title":"Clinical Infectious Diseases"},{"key":"10840_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-1702(99)00019-2","volume":"61","author":"S AbuBakar","year":"1999","unstructured":"AbuBakar, S. et al. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Research 61, 1\u20139 (1999).","journal-title":"Virus Research"},{"key":"10840_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/infdis\/169.4.905","volume":"169","author":"JP Alexander","year":"1994","unstructured":"Alexander, J. P., Baden, L., Pallansch, M. A. & Anderson, L. J. Enterovirus-71 Infections and Neurologic Disease - United-States, 1977\u20131991. Journal of Infectious Diseases 169, 905\u2013908 (1994).","journal-title":"Journal of Infectious Diseases"},{"key":"10840_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/13550280390173364","volume":"9","author":"J Kehle","year":"2003","unstructured":"Kehle, J., Roth, B., Metzger, C., Pfitzner, A. & Enders, G. Molecular characterization of an Enterovirus 71 causing neurological disease in Germany. Journal of Neurovirology 9, 126\u2013128 (2003).","journal-title":"Journal of Neurovirology"},{"key":"10840_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJM199909233411301","volume":"341","author":"MT Ho","year":"1999","unstructured":"Ho, M. T. et al. An epidemic of enterovirus 71 infection in Taiwan. New England Journal of Medicine 341, 929\u2013935 (1999).","journal-title":"New England Journal of Medicine"},{"key":"10840_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-94","volume":"7","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 7, 94 (2010).","journal-title":"Virol J"},{"key":"10840_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1303224","volume":"370","author":"RC Li","year":"2014","unstructured":"Li, R. C. et al. An Inactivated Enterovirus 71 Vaccine in Healthy Children. New England Journal of Medicine 370, 829\u2013837 (2014).","journal-title":"New England Journal of Medicine"},{"key":"10840_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF02879323","volume":"44","author":"F Yang","year":"2001","unstructured":"Yang, F., Jin, Q., He, Y. Q., Li, L. C. & Hou, Y. D. The complete genome of Enterovirus 71 China strain. Science in China Series C-Life Sciences 44, 178\u2013183 (2001).","journal-title":"Science in China Series C-Life Sciences"},{"key":"10840_CR12","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1128\/AAC.00934-08","volume":"53","author":"AM De Palma","year":"2009","unstructured":"De Palma, A. M. et al. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob Agents Chemother 53, 1850\u20137 (2009).","journal-title":"Antimicrob Agents Chemother"},{"key":"10840_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","volume":"26","author":"PC McMinn","year":"2002","unstructured":"McMinn, P. C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. Fems Microbiology Reviews 26, 91\u2013107 (2002).","journal-title":"Fems Microbiology Reviews"},{"key":"10840_CR14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/viro.2001.1310","volume":"293","author":"ML Li","year":"2002","unstructured":"Li, M. L. et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293, 386\u2013395 (2002).","journal-title":"Virology"},{"key":"10840_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF02256567","volume":"11","author":"SR Shih","year":"2004","unstructured":"Shih, S. R. et al. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. Journal of Biomedical Science 11, 239\u2013248 (2004).","journal-title":"Journal of Biomedical Science"},{"key":"10840_CR16","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.1073\/pnas.82.23.7870","volume":"82","author":"JR Dewet","year":"1985","unstructured":"Dewet, J. R., Wood, K. V., Helinski, D. R. & Deluca, M. Cloning of Firefly Luciferase Cdna and the Expression of Active Luciferase in Escherichia-Coli. Proceedings of the National Academy of Sciences of the United States of America 82, 7870\u20137873 (1985).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10840_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1021\/bi00620a014","volume":"16","author":"JC Matthews","year":"1977","unstructured":"Matthews, J. C., Hori, K. & Cormier, M. J. Purification and Properties of Renilla-Reniformis Luciferase. Biochemistry 16, 85\u201391 (1977).","journal-title":"Biochemistry"},{"key":"10840_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0003-2697(89)90267-4","volume":"176","author":"TM Williams","year":"1989","unstructured":"Williams, T. M., Burlein, J. E., Ogden, S., Kricka, L. J. & Kant, J. A. Advantages of Firefly Luciferase as a Reporter Gene - Application to the Interleukin-2 Gene Promoter. Analytical Biochemistry 176, 28\u201332 (1989).","journal-title":"Analytical Biochemistry"},{"key":"10840_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF01344351","volume":"110","author":"MR Bowlby","year":"1991","unstructured":"Bowlby, M. R. & Case, J. F. Flash Kinetics and Spatial Patterns of Bioluminescence in the Copepod Gaussia-Princeps. Marine Biology 110, 329\u2013336 (1991).","journal-title":"Marine Biology"},{"key":"10840_CR20","doi-asserted-by":"crossref","unstructured":"Ketteler, R., Sun, Z. R., Kovacs, K. F., He, W. W. & Seed, B. A pathway sensor for genome-wide screens of intracellular proteolytic cleavage. Genome Biology 9 (2008).","DOI":"10.1186\/gb-2008-9-4-r64"},{"key":"10840_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nmeth.2327","volume":"10","author":"E Bartok","year":"2013","unstructured":"Bartok, E. et al. iGLuc: a luciferase-based inflammasome and protease activity reporter. Nature Methods 10, 147\u2013154 (2013).","journal-title":"Nature Methods"},{"key":"10840_CR22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.56093\/ijas.v82i10.24178","volume":"82","author":"G Jethra","year":"2012","unstructured":"Jethra, G., Mishra, A. K., Pandey, P. S. & Chandrasekharan, H. Structure and function prediction of unknown wheat protein using LOMETS and I-TASSER. Indian Journal of Agricultural Sciences 82, 867\u2013874 (2012).","journal-title":"Indian Journal of Agricultural Sciences"},{"key":"10840_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nature Protocols 5, 725\u2013738 (2010).","journal-title":"Nature Protocols"},{"key":"10840_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"JY Yang","year":"2015","unstructured":"Yang, J. Y. et al. The I-TASSER Suite: protein structure and function prediction. Nature Methods 12, 7\u20138 (2015).","journal-title":"Nature Methods"},{"key":"10840_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jmb.2011.03.007","volume":"408","author":"S Cui","year":"2011","unstructured":"Cui, S. et al. Crystal structure of human enterovirus 71 3C protease. J Mol Biol 408, 449\u201361 (2011).","journal-title":"J Mol Biol"},{"key":"10840_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1128\/AAC.49.2.619-626.2005","volume":"49","author":"SL Binford","year":"2005","unstructured":"Binford, S. L. et al. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother 49, 619\u201326 (2005).","journal-title":"Antimicrob Agents Chemother"},{"key":"10840_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.antiviral.2012.12.029","volume":"97","author":"XN Zhang","year":"2013","unstructured":"Zhang, X. N. et al. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model. Antiviral Research 97, 264\u2013269 (2013).","journal-title":"Antiviral Research"},{"key":"10840_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. Y. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Journal of Biomolecular Screening 4, 67\u201373 (1999).","journal-title":"Journal of Biomolecular Screening"},{"key":"10840_CR29","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1099\/vir.0.2008\/002915-0","volume":"89","author":"M Arita","year":"2008","unstructured":"Arita, M., Wakita, T. & Shimizu, H. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. Journal of General Virology 89, 2518\u20132530 (2008).","journal-title":"Journal of General Virology"},{"key":"10840_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.antiviral.2013.11.002","volume":"101","author":"ZW Guo","year":"2014","unstructured":"Guo, Z. W. et al. A 3C(pro)-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents. Antiviral Research 101, 82\u201392 (2014).","journal-title":"Antiviral Research"},{"key":"10840_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1074-5521(99)80051-9","volume":"6","author":"NP Mahajan","year":"1999","unstructured":"Mahajan, N. P., Harrison-Shostak, D. C., Michaux, J. & Herman, B. Novel mutant green fluorescent protein protease substrates reveal the activation of specific caspases during apoptosis. Chemistry & Biology 6, 401\u2013409 (1999).","journal-title":"Chemistry & Biology"},{"key":"10840_CR32","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1016\/j.bmcl.2013.06.081","volume":"23","author":"RN Adamek","year":"2013","unstructured":"Adamek, R. N., Maniquis, R. V., Khakoo, S., Bridges, M. D. & Salzameda, N. T. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters 23, 4848\u20134850 (2013).","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10840_CR33","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1128\/JVI.01348-12","volume":"86","author":"Y Kim","year":"2012","unstructured":"Kim, Y. et al. Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses. Journal of Virology 86, 11754\u201311762 (2012).","journal-title":"Journal of Virology"},{"key":"10840_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ymthe.2004.10.016","volume":"11","author":"BA Tannous","year":"2005","unstructured":"Tannous, B. A., Kim, D. E., Fernandez, J. L., Weissleder, R. & Breakefield, X. O. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Molecular Therapy 11, 435\u2013443 (2005).","journal-title":"Molecular Therapy"},{"key":"10840_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11307-007-0101-8","volume":"9","author":"KM Venisnik","year":"2007","unstructured":"Venisnik, K. M., Olafsen, T., Gambhir, S. S. & Wu, A. M. Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging. Molecular Imaging and Biology 9, 267\u2013277 (2007).","journal-title":"Molecular Imaging and Biology"},{"key":"10840_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nmeth.1177","volume":"5","author":"T Wurdinger","year":"2008","unstructured":"Wurdinger, T. et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nature Methods 5, 171\u2013173 (2008).","journal-title":"Nature Methods"},{"key":"10840_CR37","first-page":"151","volume":"22","author":"M Pizzi","year":"1950","unstructured":"Pizzi, M. Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method. Hum Biol 22, 151\u201390 (1950).","journal-title":"Hum Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10840-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T14:54:10Z","timestamp":1719413650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10840"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10840-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]},"assertion":[{"value":"5 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10385"}}